|
SMC5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.009400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.100000E-01 |
| Normal-vs-Stage2 |
9.058800E-01 |
| Normal-vs-Stage3 |
2.823700E-02 |
| Normal-vs-Stage4 |
1.126020E-02 |
| Stage1-vs-Stage2 |
8.794600E-01 |
| Stage1-vs-Stage3 |
1.296680E-03 |
| Stage1-vs-Stage4 |
3.783800E-04 |
| Stage2-vs-Stage3 |
1.521570E-01 |
| Stage2-vs-Stage4 |
1.012020E-01 |
| Stage3-vs-Stage4 |
6.774200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.041000E-01 |
| Normal-vs-AfricanAmerican |
8.877400E-01 |
| Normal-vs-Asian |
2.701800E-01 |
| Caucasian-vs-AfricanAmerican |
5.487200E-01 |
| Caucasian-vs-Asian |
2.280400E-01 |
| AfricanAmerican-vs-Asian |
3.405000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.106600E-01 |
| Normal-vs-Female |
9.758600E-01 |
| Male-vs-Female |
1.266950E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.628000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.683400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.250200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.534390E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.985800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.373600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.965800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.518190E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.157800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.246800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.139700E-03 |
| Normal-vs-Grade 2 |
2.078800E-01 |
| Normal-vs-Grade 3 |
9.543500E-03 |
| Normal-vs-Grade 4 |
8.756800E-04 |
| Grade 1-vs-Grade 2 |
1.326600E-01 |
| Grade 1-vs-Grade 3 |
1.80469999999655E-05 |
| Grade 1-vs-Grade 4 |
2.35789999999403E-05 |
| Grade 2-vs-Grade 3 |
3.58840000003191E-06 |
| Grade 2-vs-Grade 4 |
1.05029999997175E-06 |
| Grade 3-vs-Grade 4 |
6.183700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.591800E-02 |
| Normal-vs-ccB subtype |
1.504100E-02 |
| ccA subtype-vs-ccB subtype |
9.42470000042661E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.327600E-01 |
| Normal-vs-N1 |
6.917800E-02 |
| N0-vs-N1 |
2.194400E-01 |
|
|
